Meningioma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) (Created page with "{{Meningioma}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Oncology Category:Neurology [[Category...") |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
The reasons of developing meningioma are not clear. Epidemiological survey demonstrates the folling measure may be helpful: | |||
:*Avoidance over-dosage radiation therapy on head. | |||
:*Early screening of disorder neurofibromatosis type 2. | |||
==References== | ==References== | ||
Revision as of 04:37, 30 January 2012
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Meningioma secondary prevention |
|
Risk calculators and risk factors for Meningioma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The reasons of developing meningioma are not clear. Epidemiological survey demonstrates the folling measure may be helpful:
- Avoidance over-dosage radiation therapy on head.
- Early screening of disorder neurofibromatosis type 2.